These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37990867)

  • 41. Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene.
    Upadhyaya M; Osborn MJ; Maynard J; Kim MR; Tamanoi F; Cooper DN
    Hum Genet; 1997 Jan; 99(1):88-92. PubMed ID: 9003501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of nerves in neurofibromatosis type 1-related nervous system tumors.
    Ge LL; Xing MY; Zhang HB; Li QF; Wang ZC
    Cell Oncol (Dordr); 2022 Dec; 45(6):1137-1153. PubMed ID: 36327093
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.
    Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF
    Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient-derived iPSC-cerebral organoid modeling of the 17q11.2 microdeletion syndrome establishes CRLF3 as a critical regulator of neurogenesis.
    Wegscheid ML; Anastasaki C; Hartigan KA; Cobb OM; Papke JB; Traber JN; Morris SM; Gutmann DH
    Cell Rep; 2021 Jul; 36(1):109315. PubMed ID: 34233200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rare NF1 Gene Mutation in Chinese Patient with Neurofibromatosis Type 1 and Anaplastic Astrocytoma.
    Zhou S; Zhu Y; Xu J; Tao R; Yuan S
    World Neurosurg; 2020 Feb; 134():434-437. PubMed ID: 31678437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.
    Williams KB; Largaespada DA
    Genes (Basel); 2020 Apr; 11(5):. PubMed ID: 32353955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.
    Dasgupta B; Yi Y; Chen DY; Weber JD; Gutmann DH
    Cancer Res; 2005 Apr; 65(7):2755-60. PubMed ID: 15805275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging.
    Su W; Xing R; Guha A; Gutmann DH; Sherman LS
    Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurofibromin Deficiency Causes Epidermal Growth Factor Receptor Upregulation through the Activation of Ras/ERK/SP1 Signaling Pathway in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheet Tumor.
    Park GH; Lee SJ; Lee CG; Kim J; Park E; Jeong SY
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Identification of a novel NF1 mutation in a Chinese family affected with neurofibromatosis type I].
    Zhang Q; Liang Y; Gao A; Duan C; Ding Y; Pan Y; Qiao L; Li H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Feb; 36(2):132-135. PubMed ID: 30703230
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NF1 frameshift mutation (c.6520_6523delGAGA) association with nervous system tumors and bone abnormalities in a Chinese patient with neurofibromatosis type 1.
    Su SY; Zhou X; Pang XM; Chen CY; Li SH; Liu JL
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurofibromin (Nf1) is required for skeletal muscle development.
    Kossler N; Stricker S; Rödelsperger C; Robinson PN; Kim J; Dietrich C; Osswald M; Kühnisch J; Stevenson DA; Braun T; Mundlos S; Kolanczyk M
    Hum Mol Genet; 2011 Jul; 20(14):2697-709. PubMed ID: 21478499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The spectrum of NF1 mutations in Korean patients with neurofibromatosis type 1.
    Jeong SY; Park SJ; Kim HJ
    J Korean Med Sci; 2006 Feb; 21(1):107-12. PubMed ID: 16479075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity.
    Tong J; Hannan F; Zhu Y; Bernards A; Zhong Y
    Nat Neurosci; 2002 Feb; 5(2):95-6. PubMed ID: 11788835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurofibromatosis 1: closing the GAP between mice and men.
    Dasgupta B; Gutmann DH
    Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Developmental abnormalities and cancer predisposition in neurofibromatosis type 1.
    Larizza L; Gervasini C; Natacci F; Riva P
    Curr Mol Med; 2009 Jun; 9(5):634-53. PubMed ID: 19601812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neurofibromin in the brain.
    Gutmann DH
    J Child Neurol; 2002 Aug; 17(8):592-601; discussion 602-4, 646-51. PubMed ID: 12403558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I.
    Li K; Turner AN; Chen M; Brosius SN; Schoeb TR; Messiaen LM; Bedwell DM; Zinn KR; Anastasaki C; Gutmann DH; Korf BR; Kesterson RA
    Dis Model Mech; 2016 Jul; 9(7):759-67. PubMed ID: 27482814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening 500 unselected neurofibromatosis 1 patients for deletions of the NF1 gene.
    Kluwe L; Siebert R; Gesk S; Friedrich RE; Tinschert S; Kehrer-Sawatzki H; Mautner VF
    Hum Mutat; 2004 Feb; 23(2):111-116. PubMed ID: 14722914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen's disease.
    Kimura N; Watanabe T; Fukase M; Wakita A; Noshiro T; Kimura I
    Mod Pathol; 2002 Mar; 15(3):183-8. PubMed ID: 11904334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.